Reuters logo
8 months ago
BRIEF-Positive phase III results of Genentech's Investigational Medicine Ocrevus published in New England Journal of Medicine
December 21, 2016 / 10:30 PM / 8 months ago

BRIEF-Positive phase III results of Genentech's Investigational Medicine Ocrevus published in New England Journal of Medicine

Dec 21 (Reuters) - Roche Holding Ag

* Ocrevus demonstrated a favorable safety profile in three large phase III studies

* Primary endpoint was met in all three studies for Ocrevus

* Positive phase III results of Genentech's Investigational Medicine Ocrevus (Ocrelizumab) published in New England Journal of Medicine Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below